SpeeDx

About:

SpeeDx is a provider of innovative multiplex and isothermal amplification solutions for clinical diagnostics.

Twitter/X: speedx

Top Investors: Tenmile, Northpond Ventures, CARB-X, Platinum Asset Management, NSW Medical Devices Fund

Description:

SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.

Total Funding Amount:

$59.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sydney, New South Wales, Australia

Founded Date:

2009-01-01

Contact Email:

sales(AT)speedx.com.au

Founders:

Alison Todd

Number of Employees:

51-100

Last Funding Date:

2023-02-28

IPO Status:

Private

Industries: